| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |